許景盛 副教授

許景盛醫師

 

最高學歷:台灣大學臨床醫學研究所博士

專長:西醫臨床訓練

電子信箱:hsu_chingsheng@tzuchi.com.tw

 

 

 

 

 

現職:

慈濟大學學士後中醫學系專任副教授

佛教慈濟醫療財團法人 台北慈濟醫院腸胃科主治醫師

學歷:

台灣大學臨床醫學研究所博士

台北縣立醫院實診科/健檢室/內視鏡及超音波室主任

台北縣立板橋醫院        內科主治醫師

慈濟大學醫學系兼任副教授

學術著作:

  1. Hsu CS, Kao JH, Chao YC, Lin HH, Fan YC, Huang CJ, Tsai PS. Interferon-based Therapy Reduces Risk of Stroke in Chronic Hepatitis C Patients: a population-based Cohort Study in Taiwan. Aliment Pharmacol Ther. 2013 Aug;38(4):415-23 (SCI).
  2. Hsu CS, Huang CJ, Kao JH, Lin HH, Chao YC, Fan YC, Tsai PS. Interferon-based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients. PLos ONE. 2013 Jul 23;8(7):e70458. (SCI)
  3. Hsu CS, Hsu SJ, Chen HC, Liu CH, Jeng J, Liu CJ, Chen PJ, Chen DS, Kao JH. Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients. Hepatol Int. 2013 7:171-179. (SCI)
  4. Hsu CS, Liu CH, Liu CJ, Wang CC, Tseng TC, Chen CL, Chen PJ, Chen DS, Kao JH. Impact of Hepatitis B Virus infection on Metabolic Profiles and Modifying Factors. J Viral Hepat. 2012 Feb;19(2):e48-57. (SCI)
  5. Hsu CS, Hsu SJ, Chen HC, Tseng TC, Liu CH, Niu WF, Jeng J, Liu CJ, Lai MY, Chen PJ, Kao JH, Chen DS. Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy. Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3719-24. (SCI)